α-突触核蛋白促进小鼠模型少突胶质细胞中神经丝轻链的表达和释放:对多系统萎缩的启示?

α-Synuclein Promotes the Expression and Release of Neurofilament Light Chain from Oligodendrocytes in a Murine Model: Implication for Multiple System Atrophy?

作者信息Yuanchu Zheng, Wenyi Kou, Gengxuan Yang, Huihui Cai, Chen Yang, Siming Li, Bingxu Zhu, Jiayi Wu, Yue Huang, Zhenwei Yu, Tao Feng
PMID40781879
发布时间2025-12
DOI10.1002/ana.70029

实验完整度

包含细胞系、动物脑组织、患者脑与血浆样本,以及分子与流式验证,但缺少体内功能验证和独立机制验证。

主要模型

MO3.13人少突胶质细胞系 野生型小鼠脑组织 MSA患者脑桥组织及血浆样本

重点核对

MO3.13细胞α-syn过表达或PFFs处理条件 NfL siRNA序列及转染条件 血浆ODEVs免疫捕获和流式检测方案 MSA患者与其他组的临床特征匹配

摘要

Objective: The understanding of neurofilament light chain (NfL) presence and release in oligodendrocytes is limited. This study aims to determine the NfL expression in oligodendrocytes, investigate whether excess ɑ-synuclein (α-syn) impacts NfL expression, release, and functions in oligodendrocytes, as well as detect plasma NfL-positive oligodendrocyte-derived extracellular vesicles (ODEVs) changes in patients with multiple system atrophy (MSA), Parkinson's disease (PD), and healthy controls (HCs). Methods: NfL expression in oligodendrocytes was assessed using RNAscope and immunofluorescence staining in human and mouse brain slices, as well as flow cytometry in mouse brain single-cells. The MO3.13 oligodendrocyte cell line was used to mimic MSA pathology with α-syn overexpression or preformed fibril treatment. NfL levels were detected in cell line, brain tissues and condition media, and the differences between MSA pathology and controls were compared. Plasma NfL-positive ODEVs were quantified using nano-scale flow cytometry in a cohort of 101 MSA patients, 96 PD patients, and 97 HCs. Results: Both NEFL mRNA and NfL protein showed co-localization with typical oligodendrocyte marker anti-2,3-cyclic nucleotide-3-phosphodiesterase (CNPase). A total of 58.5% of CNPase-positive oligodendrocytes co-expressed NfL. Increased α-syn load elevates NfL expression in both oligodendrocyte cell line and MSA patient brain slices. NfL overexpression inhibited oligodendrocyte maturation, but did not affect α-syn-induced cell viability deficits. α-Syn promoted oligodendrocytic NfL release via extracellular vesicles. Plasma NfL-positive ODEVs were elevated in MSA patients compared to PD and HCs. Interpretation: These findings suggest additional cellular roles for NfL in oligodendrocytes beyond its established function in neurons and have potential implications for the neurodegenerative pathophysiology of MSA. ANN NEUROL 2025;98:1364-1379.

实验结论

提炼研究问题、关键发现与证据,快速把握文章的核心贡献。

研究问题
NfL是否在少突胶质细胞中表达,α-syn负担是否影响其表达与释放,以及血浆NfL阳性ODEVs是否能区分MSA与PD。
核心机制
α-syn负担促进少突胶质细胞NfL表达并通过细胞外囊泡释放,涉及内体途径。
主要证据
人脑和鼠脑组织共定位、MO3.13细胞实验、MSA患者脑切片及血浆样本流式检测。
研究意义
少突胶质细胞来源的NfL阳性EVs可能作为MSA的潜在生物标志物,并揭示新的病理机制。

研究路径

按研究推进顺序梳理实验设计、验证步骤与关键观察。

1

检测NfL在少突胶质细胞中的表达

验证NfL是否在少突胶质细胞中表达

使用RNAscope和免疫荧光共染色人脑和鼠脑切片,流式分析鼠脑单细胞悬液,Western blot检测细胞系。

2

模拟MSA病理改变

检测α-syn负担对NfL表达的影响

在MO3.13细胞中过表达α-syn或用PFFs处理,检测NEFL mRNA和NfL蛋白表达。

3

验证NfL功能

评估NfL对少突胶质细胞成熟和活力的影响

在分化培养基中培养MO3.13细胞,过表达或敲低NfL,检测CNPase表达和细胞活力。

4

探究NfL释放机制

确定α-syn是否通过EVs促进NfL释放

超速离心收集EVs,ELISA检测NfL浓度,纳米流式检测NfL阳性EVs,免疫荧光检测共定位。

5

临床验证

比较MSA、PD和HC血浆中NfL阳性ODEVs水平

使用免疫捕获分离ODEVs,纳米流式检测NfL阳性EVs和ODEVs浓度。

研究方法

按研究目的归类文中使用的方法,便于定位所需技术。

产品清单

实验环节名称品牌货号
抗NfL抗体Santa Cruz Biotechnologysc-20012
抗CNPase抗体Proteintech12422-1-AP
RNAscope多重荧光试剂盒v2Advanced Cell Diagnostics323110
RNA-蛋白共检测辅助试剂盒Advanced Cell Diagnostics323180
抗NfL抗体--sc-20012
抗CNPase抗体Abcamab6319
抗β-肌动蛋白抗体Sigma-AldrichA5441-100UL
CytoFLEX S流式细胞仪Beckman Coulter--
MO3.13细胞系Cedarlane Labs--
SH-SY5Y细胞系Procell Life Science and Technology--
MN9D细胞系American Type Culture Collection--
SVG p12细胞系American Type Culture Collection--
DMEM培养基GibcoC11995500BT
胎牛血清----
青霉素----
链霉素----
jetPRIME转染试剂Polyplus101000046
α-突触核蛋白预形成纤维----
转铁蛋白----
胰岛素----
孕酮----
腐胺----
谷氨酰胺----
4-β-佛波醇-12-肉豆蔻酸酯-13-乙酸酯----
RNAsimple总RNA提取试剂盒Tiangen BiotechDP419
逆转录系统PromegaA3500
PowerUp SYBR Green预混液Thermo Fisher ScientificA25742
QuantStudio 5实时荧光定量PCR系统Thermo Fisher Scientific--
SDS-PAGE凝胶GenscriptM42010C
增强化学发光试剂LableadE1060
Bio-Rad Chemidoc MP成像系统Bio-Rad--
MTT细胞增殖和细胞毒性检测试剂盒Beyotime BiotechnologyC0009SS
Dynabeads抗体偶联试剂盒Thermo Fisher Scientific14311D
M-270环氧磁珠Thermo Fisher Scientific--
人NfL ELISA试剂盒CUSABIOCSB-E16094h
BCA蛋白定量试剂盒Thermo Fisher Scientific23225
ZetaView平台Particle Metrix--
Alexa Fluor 647小鼠IgG1标记试剂盒Thermo Fisher ScientificZ25008
Alexa Fluor 488小鼠IgG1标记试剂盒Thermo Fisher ScientificZ25002
Tecnai Spirit透射电子显微镜D1297FEI Company--
冷冻切片机Leica Biosystems--

关键环节

汇总复现实验时建议重点确认的条件及原文阅读提示。

环节核对要点
组织切片
脑组织来源、切片厚度、固定和脱水步骤
阅读提示:Methods: Human and Mouse Brain Slices Preparation
RNAscope
探针浓度、杂交温度和缓冲液配方
阅读提示:Methods: RNAscope In Situ Hybridization with Protein Co-detection
免疫荧光
抗体浓度、孵育温度和缓冲液
阅读提示:Methods: Immunofluorescence Staining
细胞培养
细胞系来源、培养基成分、转染或PFFs处理条件
阅读提示:Methods: Cell Cultures
EVs分离
离心转速和时间、抗体包被条件、血浆稀释倍数
阅读提示:Methods: EVs Isolation
纳米流式
抗体标记浓度、孵育时间、仪器设置(VSSC模式)
阅读提示:Methods: EVs Analysis with Cytoflex Nano-Scale Flow Cytometry
临床队列
纳入标准、排除标准、样本量、疾病严重度评分
阅读提示:Methods: Participants and Table 2